ORF38 has been shown experimentally to be an abundant tegument protein and a critical virion component.
| Inventor | Institute |
|---|---|
| Fanxiu Zhu | Florida State University Research Foundation |
| Cat. #: | 160639 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Genetics;Microbiology |
| Application: | IP |
| Target: | Open Reading Frame 38 |
| Reactivity: | Other Species |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | Kaposi's sarcoma-associated herpesvirus (KSHV) has been identified as the causative agent of Kaposi's sarcoma, the most common malignancy in HIV-infected individuals. KSHV has also been shown to be be associated with two lymphoproliferative diseases (Fu et al., 2015). Open reading frame 38 (ORF38) (tegument) is a gene associated with the late lytic viral life cycle of KSHV. This anti-ORF38 (tegument) was generated using a baculovirus-synthesized ORF38 as an antigen. ORF38 has been shown to be a critical binding partner for ORF33. The interaction of ORF33 and ORF38 plays an important role in the transport of newly assembled viral particles through vesicles. ORF38 has been shown experimentally to be an abundant tegument protein and a critical virion component. Conserved interaction between ORF33 and ORF38 homologues plays critical roles in the production of progeny virions but are not essential for viral gene expression. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG |
| Immunogen: | A baculovirus-synthesized ORF38 was used as an antigen |
| Target background: | Kaposi's sarcoma-associated herpesvirus (KSHV) has been identified as the causative agent of Kaposi's sarcoma, the most common malignancy in HIV-infected individuals. KSHV has also been shown to be be associated with two lymphoproliferative diseases (Fu et al., 2015).Open reading frame 38 (ORF38) (tegument) is a gene associated with the late lytic viral life cycle of KSHV. This anti-ORF38 (tegument) was generated using a baculovirus-synthesized ORF38 as an antigen. ORF38 has been shown to be a critical binding partner for ORF33. The interaction of ORF33 and ORF38 plays an important role in the transport of newly assembled viral particles through vesicles. ORF38 has been shown experimentally to be an abundant tegument protein and a critical virion component. Conserved interaction between ORF33 and ORF38 homologues plays critical roles in the production of progeny virions but are not essential for viral gene expression. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Wu et al. 2016. J Virol. 90(4):1741-56. PMID: 26637455. Gillen et al. 2015. J Virol. 89(9):4918-31. PMID: 25694600. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.